Cardiopolymers;Henry Ford Health System; Inc.;Cardiopolymers, Inc.;The Regents of the University of California
发明人:
Lee, Randall J.,Sabbah, Hani N.,Hinson, Andrew G.
申请号：
AU2007292923
公开号：
AU2007292923B2
申请日:
2007.09.07
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Cardiomyopathy may be treated by distributing space-occupying agent withinthe myocardium in a pattern about one or more chambers of the heart, such that thespace-modifying agent integrates into and thickens at least part of the cardiacwall about the chamber so as globally to reduce wall stress and stabilize or evenreduce chamber size. Some patterns also cause a beneficial global reshapingof the chamber. Specific cardiac conditions treatable by these systems and methodsinclude, dilated cardiomyopathy (with or without overt aneurismal formations),congestive heart failure, and ventricular arrhythmias, myocardial infarctions,overt aneurysm of the ventricular wall as typically forms in response to largetransmural myocardial infarctions, and mitral regurgitation due to a noncompliantmitral valve.
